Etiology and pathogenesis of atrial fibrillation

Atrial Fibrillation

Volumn , Issue , 2004, Pages 27-60

  Podrid, Philip J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35948941838     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (199)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155:469–473.
2. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994–1998: analysis of data from the general practice research database. Heart 2001; 86:284–288.
3. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiology of atrial fibrillation: the Framingham study. N Engl J Med 1982; 306:1018–1022.
4. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285:2370–2375.
5. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-up Study. Am J Med 1995; 98:476–484.
6. Benjamin EJ, Wolf PA, D’Agostino RB, McNamara PM. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98:946–952.
7. Davies MD, Pomerance A. Pathology of atrial fibrillation in man. Br Heart J 1972; 34:520–525.
8. Lie JT, Falk RH, James TN. Cardiac anatomy and pathologic correlates of atrial fibrillation. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanisms and Management. 2d ed. Philadelphia: Lippincott-Raven, 1997:23–52.
9. Lie TJ, Hammond PI. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 1988; 63:552–564.
10. Sopher SM, Malik M, Camm AJ. Neural aspects of atrial fibrillation. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanisms and Management. 2d ed. Philadelphia: Lippincott-Raven, 1997:155–167.
11. Kerr CR, Leather RA. Atrial fibrillation in the absence of overt cardiac disease. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanisms and Management. 2d ed. Philadelphia: Lippincott-Raven, 1997:169–182.
12. Evans W, Swann P. Lone atrial fibrillation. Br Heart J 1954; 6:189–194.
13. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation: thirty-year follow-up in the Framingham study. JAMA 1985; 254:3449–3453.
14. Kopecky SL, Gersh BJ, McGoon MD, Chu CP, Ilstrup DM, Chesebro JH, Whisnant JP. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987; 317:669–674.
15. Kannel WB, Abbott RD, Savage DD. Coronary heart disease and atrial fibrillation: the Framingham study. Am Heart J 1983; 106:386–396.
16. Benjamin EL, Levy D, Vairi SM, Agostino D’RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271:840–844.
17. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD. A comparison of rate control and rhythm control in patients with atrial fibrillation. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) investigators. N Engl J Med 2002; 347:1825–1833.
18. Verdecchia P, Reboldi G, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F, Carluccio E, Sardone MG, Porcellati C. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 2003; 41:218–223.
19. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Study. Circulation 1994; 89:724–730.
20. Tsang TS, Barnes ME, Bailey KR, Leibson CL, Montgomery SC, Takemoto Y, Diamond PM, Marra MA, Gersh BJ, Wiebers DO, Petty GW, Seward JB. Left atrial volume: important risk marker of incidental atrial fibrillation in 1655 older men and women. Mayo Clin Proc 2001; 76:467–475.
21. Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, Dahlof B, Devereux RB. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) study. Hypertension 2002; 39:739–743.
22. Dittrich HC, Pearce LE, Asinger RW, Mcbride R, Webel R, Zabalgiotia M, Pennock GD, Stafford RE, Rothbart RM, Halperin JL, Hart RG. Left atrial diameter in nonvalvular atrial fibrillation. An echocardiographic study. Stroke prevention in Atrial Fibrillation Investigators. Am Heart J 1999; 137:494–499.
23. Haddad AH, Pihkov VK, Dean DC. Chronic atrial fibrillation and coronary artery disease. J Electrocardiol 1978; 11:67–69.
24. Kramer RJ, Zeldis SM, Hamby RI. Atrial fibrillation, a marker for abnormal left ventricular function in coronary heart disease. Br Heart J 1982; 47:606–608.
25. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol 1988; 61:714–717.
26. Celik SV, Erdol C, Baykan M, Ian S, Kasap H. Relation between paroxysmal atrial fibrillation and left ventricular diastolic function in patients with acute myocardial infarction. Am J Cardiol 2001; 88:160–162.
27. Liem KL, Lie KI, Durrer D, Wellens HJ. Clinical setting and prognostic significance of atrial fibrillation complicating acute myocardial infarction. Eur J Cardiol 1976; 4:59–62.
28. Liberthson RR, Salesbury KW, Hutten AM, De Sanctis RW. Atrial tachyarrhythmias in acute myocardial infarction. Am J Med 1976; 60:956–960.
29. Cristal N, Scwarzberg J, Gueron M. Supraventricular arrhythmias in acute myocardial infarction: Prognostic importance of clinical setting: mechanism of production. Ann Intern Med 1975; 82:35–39.
30. Nagahama Y, Sugiura T, Takehana K, Hatada K, Inada M, Iwasaka T. The role of infarction-associated pericarditis on the occurrence of atrial fibrillation. Eur Heart J 1998; 19:287–292.
31. Goldberg RJ, Seeley D, Becker RC, Brady P, Chen ZY, Osganian V, Gore JM, Alpert JS, Dalen JE. Impact of atrial fibrillation of the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. Am Heart J 1990; 119:996–1001.
32. Jewitt DE, Balcon R, Raftery EB, Oram S. Incidence and management of supraventricular arrhythmias after acute myocardial infarction. Am Heart J 1969; 77:290–293.
33. James TN. Myocardial infarction and atrial arrhythmias. Circulation 1961; 24:761.
34. Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J 2000; 140:878–885.
35. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM, for the GUSTO-1 Trial Investigators. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-1 experience. J Am Coll Cardiol 1997; 30:40413.
36. Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP, Santoro L, Tognoni G. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart 2001; 86:527–532.
37. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. The occurrence and prognostic significance of atrial fibrillation/flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evaluation. Eur Heart J 1999; 20:748–754.
38. Behar S, Zahavi Z, Goldbourt U, Reicher Reiss H. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT study group. Eur Heart J 1992; 13:45–50.
39. Hod H, Lew AS, Keltae M, Cercek B, Geft IL, Shah PK, Ganz W. Early atrial fibrillation during evolving myocardial infarction. Circulation 1987; 75:146–150.
40. Sakata K, Kurihara H, Iwamori K, Maki A, Yoshino H, Yanagisawa A, Ishikawa K. Clinical and prognositc significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol 1997; 80:1522–1527.
41. Eldar M, Canettii M, Rotstein Z, Boyko V, Gottlieb S, Kaplinsky E, Behar S, for the SPRINT and Thrombolytic Survey Groups. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. Circulation 1998; 97:965–970.
42. Al-Khatib SM, Pieper KS, Lee KL, Mahaffey KW, Hochman JS, Pepine CJ, Kopecky SL, Akkerhuis M, Stepinska J, Simoons ML, Topol EJ, Califf RM, Harrington RA. Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. Am J Cardiol 2001; 88(A7):76–79.
43. Friedman HZ, Weber-Bornstein N, Deboe SF, Mancini GB. CCU admission criteria for suspected acute myocardial infarction in new onset atrial fibrillation. Am J Cardiol 1987; 59:866–869.
44. Shlofmitz RA, Hirsh BE, Meyer BR. New onset atrial fibrillation: is there a need for emergent hospitalization? J Gen Intern Med 1986; 1:139–192.
45. Zimetbaum PJ, Josephon ME, McDonald MJ, McClennen S, Korley V, Ho KK, Papageorgiou P, Cohen DJ. Incidence and predictors of myocardial infarction among patients with atrial fibrillation. J Am Coll Cardiol 2000; 36:1223–1227.
46. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91:2D-8D.
47. Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA, Saxon LA, Natterson DP, Steimle A, Walden JA, Tillisch JH. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 1996; 28:1458–1463.
48. Ehrlich JR, Nattel S, Hohnloser SH. Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol 2002; 13:399–405.
49. Van Gelder IC, Crijns JGM, Blanksma PK, Landsman ML, Posma JL, Van Den Berg MP, Meijler FL, Lie KI. Time course of hemodynamic changes and improvement in exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 1993; 72:560–566.
50. Alam M, Thorstrand C. Left ventricular function in patients with atrial fibrillation before and after cardioversion. Am J Cardiol 1992; 69:694–696.
51. Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 1998; 32:197–204.
52. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69:1570–1573.
53. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994; 74:236–241.
54. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors and prognosis in the Manitoba Follow-up Study. Am J Med 1995; 98:476–484.
55. Flaker GC, Fletcher KA, Rothbart RM, Halperin JL, Hart RG. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Am J Cardiol 1995; 76:355–358.
56. Yamada T, Fukunami M, Shimonagata T, Kumagai K, Ogita H, Asano Y, Hirata A, Hori M, Hoki N. Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study. J Am Coll Cardiol 2000; 35:405–413.
57. Hornestam B, Hall C, Held P, Carlsson T, Falk L, Karlson BW, Lundstrom T, Peterson M, for the Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. N-terminal proANF in acute atrial fibrillation: a biochemical marker of atrial pressures but not a predictor for conversion to sinus rhythm. Am Heart J 1998; 135:1040–1047.
58. Rossi A, Enriquez-Sarano M, Burnett JC, Lerman A, Abel MD, Seward JB. Natriuretic peptide levels in atrial fibrillation. A prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 2000; 35:1256–1262.
59. Francis GS. Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. Am J Cardiol 1986; 57:3B-7B.
60. Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 1990; 15:1279–1285.
61. Cecchi F, Olivotto I, Montereggi A, Marconi P, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995; 26:1529–1536.
62. Savage DD, Seides SF, Maron BJ, Myers DJ, Epstein SE. Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 1979; 59:866–875.
63. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001; 104:2517.
64. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. Hypertrophic cardiomyopathy. The importance of the site and extent of hypertrophy. A review. Prog Cardiovasc Dis 1985; 28:1–83.
65. McKenna WJ, England D, Dor YL, Deanfield JE, Oakley C, Goodwin JF. Arrhythmia in hypertrophic cardiomyopathy: influence on prognosis. Br Heart J 1981; 46:168–172.
66. Gleaney DL, O’Brien KP, Gold HK. Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis. Br Heart J 1970; 32:652–659.
67. Stafford WJ, Trohman RG, Bilsker M, Zaman L, Castellanos A, Myerburg RJ. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 7:701–704.
68. Suzuki M, Hirayama T, Marumoto K, Okayama H, Iwata T. Paroxysmal atrial fibrillation as a cause of potentially lethal ventricular arrthythmia with myocardial ischemia in hypertrophic cardiomyopathy: a case report. Angiology 1998; 49:653–657.
69. Falk RH. Cardiac amyloidosis. Prog Cardiol 1989; 2:143–156.
70. Hodkinson HM, Pomerance A. The clinical pathology of heart failure and atrial fibrillation in old age. Postgrad Med 1979; 55:251.
71. Crijns HJ, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, van den Berg MP, van Veldhuisen DJ. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 2000;21:1238–1245.
72. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol 1998; 32:695–703.
73. Mahoney P, Kimmel S, DeNofrio D, Wahl P, Loh E. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol 1999; 83:1544–1547.
74. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87:VI102-VI110.
75. Bentivoglio LG, Uricchio JF, Waldo A, et al. An electrocardiographic analysis of sixty five cases of mitral regurgitation. Circulation 1958; 18:572.
76. Rowe JC, Bland EF, Sprague HB, White PD. The course of mitral stenosis without surgery: ten and twenty year perspectives. Ann Intern Med 1960; 52:741.
77. Olesen KH. The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J 1962; 24:349.
78. Probst P, Goldschlager N, Selzer A. Left atrial size and atrial fibrillation in mitral stenosis: Factors influencing their relationship. Circulation 1973; 48:1282–1287.
79. Graham GK, Taylor JA, Ellis LB, Greenberg DJ, Robbins SL. Studies in mitral stenosis: a correlation of post-mortem findings with the clinical course in the disease in one hundred and one cases. Arch Intern Med 1951; 88:532–547.
80. Stone SJ, Feil HS. Mitral stenosis: a clinical and pathologic study of 100 cases. Am Heart J 1933; 9:53–62.
81. Podrid PJ, Falk RH. Management of atrial fibrillation: an overview. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanism and Management. New York: Raven Press, 1992:389–411.
82. Grigioni F, Avierinos JF, Ling LH, Scott CG, Bailey KR, Tajik AJ, Frye RL, Enriquez-Sarano M. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol 2002; 40:84–92.
83. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 1999; 99:1851–1857.
84. Rothschild MA, Sachs B, Libman E. The disturbances of the cardiac mechanism in subacute bacterial endocarditis and rheumatic fever. Am Heart J 1927; 2:316–374.
85. Fulton MN, Levine SA. Subacute bacterial endocarditis, with special references to the valve lesions and previous history. Am J Med Sci 1932; 183:60–77.
86. Diker E, Aydogdu S, Ozdemir M, Kural T, Polat K, Cehreli S, Erdogan A, Goksel S. Prevalence and predictors of atrial fibrillation in rheumatic heart disease. Am J Cardiol 1996; 77:93–98.
87. Aronow WS, Schomoetz KS, Koenigsberg M. Correlation of atrial fibrillation with presence or absence of mitral annular calcium in 604 patients older than 60 years. Am J Cardiol 1987; 59:1213–1214.
88. Savage DD, Garrison RJ, Castelli WP, McNamara PM, Anderson SI, Kannel WB, Feinleib M. Prevalence of saturated (annular) calcium and its correlates in a general population-based sample. The Framingham study. Am J Cardiol 1983; 57:1375–1378.
89. Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989; 31:367–378.
90. Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 1992; 69:963–965.
91. Asher CR, Miller DP, Grimm RA, Cosgrove DM III, Chung MK. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol 1998; 82:892–895.
92. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993; 56:539–549.
93. Mueller XM, Tevaearai HT, Ruchat P, Stumpe F, von Segesser LK. Did the introduction of a minimally invasive technique change the incidence of atrial fibrillation after single internal thoracic artery-left anterior descending artery grafting? J Thorac Cardiovasc Surg 2001; 121:683–688.
94. Tamis-Holland JE, Homel P, Durani M, Iqbal M, Sutandar A, Mindich BP, Steinberg JS. Atrial fibrillation after minimally invasive direct coronary artery bypass surgery. J Am Coll Cardiol 2000; 36:1884–1888.
95. Asher CR, DiMengo JM, Arheart KL, Weber MM, Grimm RA, Blackstone EH, Cosgrove DM, Chung MK. Atrial fibrillation early postoperatively following minimally invasive cardiac valvular surgery. Am J Cardiol 1999; 84:744–749.
96. Ascione R, Caputo M, Calori G, Lloyd CT, Underwood MJ, Angelini GD. Predictors of atrial fibrillation after conventional and beating heart coronary surgery. A prospective, randomized study. Circulation 2000; 102:1530–1535.
97. d’Amato TA, Savage EB, Wiechmann RJ, Sakert T, Benckart DH, Magovern JA. Reduced incidence of atrial fibrillation with minimally invasive direct coronary artery bypass. Ann Thorac Surg 2000; 70:2013–2016.
98. Pavri BB, O’Nunain SS, Newell JB, Ruskin JN, William G. Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation. J Am Coll Cardiol 1995; 25:1673–1680.
99. Polanczyk CA, Goldman L, Marcantonio ER, Orav EJ, Lee TH. Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay. Ann Intern Med 1998; 129:279–285.
100. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135:1061–1073.
101. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, Tarazi R, Shroyer AL, Sethi GK, Grover FL, Hammermeister KE. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 1997; 226: 501–511.
102. Abreu JE, Reilly J, Salzano RP, Khachane VB, Jekel VF, Clyne CA. Comparison of frequencies of atrial fibrillation after coronary artery bypass grafting with and without the use of cardiopulmonary bypass. Am J Cardiol 1999; 83:775–776.
103. Kim MK, Deeb GM, Morady F, Bruckman D, Hallock LR, Smith KA, Karavite DJ, Bolling SF, Pagani FD, Wahr JA, Sonnad SS, Kazanjian PE, Watts C, Williams M, Eagle KA. Effect of postoperative atrial fibrillation on length of stay after cardiac surgery (the postoperative atrial fibrillation in cardiac surgery study). Am J Cardiol 2001; 87:881–885.
104. Bashur TT. Classification of sinus node dysfunction. Am Heart J 1985; 110:1251–1258.
105. Ferrer MI. The sick sinus syndrome. Cirulation 1973; 47:635–641.
106. Short DS. The syndrome of alternating bradycardia and tachycardia. Br Heart J 1954; 16:208.
107. Kaplan BM, Langendorf R, Lev M, Pick A. Tachycardia-bradycardia syndrome (so-called “sick sinus syndrome”). Pathology, mechanisms and treatment. Am J Cardiol 1973; 31:497.
108. Gomes JA, Kang PS, Matheson M, Gough WB, El-Sherif N. Coexistence of sick sinus rhythm and atrial flutter-fibrillation. Circulation 1981; 63:80–86.
109. Vallin H, Edhag V. Associated conduction disturbances in patients with symptomatic sinus node disease. Acta Med Scand 1981; 210:263–270.
110. Narula OS. Atrioventricular conduction defects in patients with sinus bradycardia. Analysis by His bundle recordings. Circulation 1971; 44:1096–1110.
111. Sutton R, Kenny RA. The natural history of sick sinus syndrome. PACE 1986; 9:1110–1114.
112. Ferrer MI. The etiology and natural history of sinus node disorders. Arch Intern Med 1982; 142:371–372.
113. Seipel L, Both A, Breithardt G, Loogen F. Action of antiarrhythmic drugs on His bundle electrogram and sinus node function. Acta Cardiol 1974; 48(suppl): 251–267.
114. Alt E, Volke R, Wirtzfeld A, et al. Survival and follow up after pacemaker implantation: a comparison of patients with sick sinus syndrome, complete heart block and atrial fibrillation. PACE 1985; 8:849–855.
115. Aeosty JM, Cohen SI, Marken E. Brady-tachycardia syndrome: results in twenty-eight patients treated by combined pharmacologic therapy and pacemaker implantation. Chest 1974; 66:257–263.
116. Bauernfiend RA, Wyndham CR, Swiryn SD, et al. Paroxysmal atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol 1981; 47:562–569.
117. Wellens HJJ, Smeets JLRC, Rodriguez LM, Gorgels APM. Atrial fibrillation in Wolff-Parkinson-White syndrome. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanism and Management. 2ded. New York: Raven Press, 1997:205–217.
118. Fuijimura O, Klein GJ, Yee R, Sharma AD. Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway? J Am Coll Cardiol 1990; 15:1082–1086.
119. Sharma AD, Klein GJ, Guirdauron GM, Milstein S. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway. Circulation 1985; 72:161–169.
120. Chen PS, Pressley JC, Tang ASL, Packer DL, Gallagher JJ, Prystowsky EN. New observations on atrial fibrillation before and after surgical treatment in patients with the Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1992; 19:974–981.
121. Morady F, Sledge C, Shen E. Electrophysiologic testing in the management of patients with the Wolff-Parkinson-White syndrome and atrial fibrillation. Am J Cardiol 1973; 51:1623–1628.
122. Klein LS, Miles WM, Zipes DP. Effect of atrioventricular interval during pacing or reciprocating tachycardia in atrial size, pressure and refractory period: contraction excitation feedback in human atrium. Circulation 1990; 82:60–68.
123. Kanter RJ, Garson A. Arrhythmias in congenital heart disease. In: Podrid PJ, Kowey PR, eds. Cardiac Arrhythmias: Mechanisms, Diagnosis, and Management. 2d ed. Philadelphia: Lippincott, Williams & Wilkins, 2001:749–783.
124. Tikoff G, Schmidt AM, Hecht HH. Atrial fibrillation in atrial septal defect. Arch Intern Med 1968; 121:402.
125. Berger F, Vogel M, Kramer A, Alexi-Meskishvili V, Weng Y, Lange PE, Hetzer R. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg 1999; 68:75–78.
126. Weber DM, Phillips JH. A reevaluation of electrocardiographic changes accompanying acute pulmonary embolism. Am J Med Sci 1966; 251:381.
127. Davidson E, Weinberger I, Rotenberg Z, Fuchs J, Agmon J. Atrial fibrillation: cause and time of onset. Arch Intern Med 1989; 149:457–459.
128. Walsh JJ, Burch GE, Black WC, et al. Idiopathic cardiomyopathy of the puerperium (post partum heart disease). Circulation 1965; 32:19.
129. Ansari A, Larson PH, Bates HD. Cardiovascular manifestations of systemic lupus erythematosus: current perspective. Prog Cardiovasc Dis 1985; 27:421–434.
130. Alexander JK. The cardiomyopathy of obesity. Prog Cardiovasc Dis 1985; 27:325–334.
131. Spodick DH. Arrhythmias during acute pericarditis. A prospective study of 100 consecutive cases. JAMA 1976; 235:39–41.
132. Levine HD. Myocardial fibrosis in constrictive pericarditis: electrocardiographic and pathologic observations. Circulation 1973; 48:1268.
133. Ristic AD, Maisch B, Hufnagel G, et al. Arrhythmias in acute pericarditis. An endomyocardial biopsy study. Herz 2000; 25:729–733.
134. Lowenstein AJ, Gaboer PA, Cramer J. The role of alcohol in new onset atrial fibrillation. Arch Intern Med 1983; 143:1882–1885.
135. Koskinen P, Kupari M, Leonine H. Alcohol and new onset atrial fibrillation: a case control study of a current series. Br Heart J 1987; 57:468–473.
136. Ettinger PV, Wu CF, De LaCruz C, Weisse AB, Ahmed SS, Regan TJ. Arrhythmias and the holiday: alcohol associated cardiac rhythm disorders. Am Heart J 1978; 95:555–562.
137. Menz V, Grimm W, Hoffmann J, Maisch B. Alcohol and rhythm disturbance: the holiday heart syndrome. Herz 1996; 21:227–231.
138. Koskinen P, Kupari M, Leonine H. Role of alcohol in recurrence of atrial fibrillation in persons less than 65 years of age. Am J Cardiol 1990; 66:954–958.
139. Engle TR, Luck JC. Effect of whisky on atrial vulnerability and holiday heart. J Am Coll Cardiol 1983; 1:816–818.
140. Gould L, Reddy LV, Becker W, et al. Electrophysiologic properties of alcohol in man. J Electrocardiol 1978; 11:219–226.
141. Gimeno AL, Bimeno MD, Webb JL. Effects of alcohol on cellular membrane potential and contractility of isolated atrium. Am J Physiol 1962; 203:194–196.
142. Hibbs RG, Ferrans VJ, Black WC. Alcohol cardiomyopathy: an electron microscopic study. Am Heart J 1965; 69:766–779.
143. Bing RJ. Cardiac metabolism: its contribution to alcoholic heart disease and myocardial failure. Circulation 1978; 58:965.
144. Thornton JR. Atrial fibrillation in healthy non-alcoholic people after an alcohol binge. Lancet 1984; 2:1013–1014.
145. Rich EC, Siebold C, Campion B. Alcohol-related acute atrial fibrillation: a case control study and review of 40 patients. Arch Intern Med 1985; 145:830–833.
146. Forfar JC, Toft AD. Thyrotoxic atrial fibrillation: an under diagnosed condition. Br Med J 1982; 285:909–910.
147. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992; 327:94–98.
148. Cobbler JL, Williams MC, Greenland P. Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation. Arch Intern Med 1984; 144:1758–1770.
149. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D’Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331:1249–1252.
150. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 2001; 142: 838–842.
151. Krahn AD, Klein GJ, Kerr CR, Boone J, Sheldon R, Green M, Talajic M, Wang X, Connolly S. How useful is thyroid function testing in patients with recent- onset atrial fibrillation? Arch Intern Med 1996; 156:2221–2224.
152. Iwasaki T, Naka H, Namatsu K, et al. Echocardiographic studies on the relationship between atrial fibrillation and atrial enlargement in patients with hyperthyroidism of Graves disease. Cardiology 1989; 76:10–17.
153. Thomas ES, Mozzferri EL, Skillman TK. Apathetic thyrotoxicosis: a distinct clinical and laboratory abnormality. Ann Intern Med 1970; 72:679–685.
154. Tajiri J, Hamasaki S, Shimade T, et al. Masked thyroid dysfunction among elderly patients with atrial fibrillation. Jpn Heart J 1986; 27:183–190.
155. Davies AV, Williams J, John R, et al. Diagnostic value of thyrotropin releasing hormone test in elderly patients with atrial fibrillation. Br Med J 1985; 291:773–776.
156. Fortar JC, Feck CM, Miller HC. Atrial fibrillation and isolated suppression of the pituitary thyroid axis to specific antithyroid therapy. Int J Cardiol 1981; 1:43–48.
157. Scott GR, Forfor JC, Toft AD. Graves disease and atrial fibrillation: the case for even high doses of therapeutic iodine-131. Br Med J 1984; 289:399–400.
158. Chen YC, Chen SA, Chen YJ, Chang MS, Chan P, Lin CI. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol 2002; 39:366–372.
159. Williams LT, Lefkowitz RJ, Witanabe AM, et al. Thyroid hormone regulation of beta adrenergic receptor number. J Biol Chem 1977; 252:2787.
160. Varriale P, Ramaprased S. Aminophylline induced atrial fibrillation. Pacing Clin Electrophysiol 1993; 16:1953–1955.
161. Elvan A, Pride HP, Eble JN, Zipes DP. Radiofrequency catheter ablation of the atria reduces inducibility and duration of atrial fibrillation in dogs. Circulation 1995;91:2235–2244.
162. Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes. The third fat pad. Circulation 1997; 95:2573–2584.
163. Sticherling C, Oral H, Horrocks J, Chough SP, Baker RL, Kim MH, Wasmer K, Pelosi F, Knight BP, Michaud GF, Strickberger SA, Morady F. Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness. Circulation 2000; 102:2503–2508.
164. Tieleman RG, Blaauw Y, Van Gelder IC, De Langen CD, de Kam PJ, Grandjean JG, Patberg KW, Bel KJ, Allessie MA, Crijns HJ. Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria. Circulation 1999; 100:1836–1842.
165. Brugada R, Tapscott T, Czernuszewicz G, Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A, Bachinski LL, Roberts R. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997; 336:905–911.
166. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003; 299:251–254.
167. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104:2886–2891.
168. Ortiz J, Niwano S, Abe H, Rudy Y, Johnson NJ, Waldo AL. Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights into mechanisms. Circ Res 1994; 74:882–894.
169. Hamer ME, Wilkinson WE, Clair WK, Page PL, McCarthy EA, Pritchett EL. Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia. J Am Coll Cardiol 1995; 25:984–988.
170. Chen YJ, Chen SA, Tai CT, Wen ZC, Feng AN, Ding YA, Chang MS. Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fibrillation. J Am Coll Cardiol 1998; 32:732–738.
171. Janse MJ, Allessie MA. Experimental observations on atrial fibrillation. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanism and Management. 2d ed. New York: Raven Press, 1997:53–73.
172. Allessie MA, Konings K, Kirchhof CJ, Wijffels M. Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol 1996; 77:10A- 23A.
173. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92:1954.
174. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats. Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 1997; 96:3710–3720.
175. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia- induced atrial electrical remodeling. Circulation 1998; 98:2202–2209.
176. Ramdat Misier AR, Opthof T, Van Hemel N. Increased dispersion of “refractoriness” in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol 1992; 19:1531–1535.
177. Roberts DE, Hersch LT, Scher AM. Influence of cardiac fiber orientation on wavefront voltage, conduction velocity and tissue resistivity in the dog. Circ Res 1979; 44:701–712.
178. Spach MS, Miller WT, Dolber PC, et al. The functional role of structural complexities in the propagation of depolarization in the atrium of the dog: cardiac conduction disturbances due to discontinuities of effective atrial resistivity. Circ Res 1982; 50:175–191.
179. Spack MS, Doeber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle: evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res 1986; 58:356–371.
180. Simpson RJ, Foster JR, Gettes LS. Atrial excitability and conduction in patients with interatrial conduction defects. Am J Cardiol 1982; 50:1331–1337.
181. Simpson RJ, Amara F, Foster JR, et al. Thresholds, refractory periods and conduction times of the normal and diseased human atrium. Am Heart J 1988; 116:1080–1090.
182. Ohe T, Matsuhia M, Kamakura S. Relation between the widening of the fragmental atrial activity zone and atrial fibrillation. Am J Cardiol 1983; 52:1219–1222.
183. Tanigawa M, Fukatani M, Konoe A. Prolonged and fractional right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrillation and sick sinus node syndrome. J Am Coll Cardiol 1991; 17:403–408.
184. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962; 140:183–188.
185. Allessie MA, Lammers WJEP, Bonke FM. Experimental evaluation of Moe’s multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP, Jalife J, eds. Cardiac Arrhythmias. Orlando, FL: Grune & Stratton, 1985:265–276.
186. Danias PG, Caulfield TA, Weigner MJ, Silverman DI, Manning WJ. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol 1998; 31:588–592.
187. Tieleman RG, De Langen CDJ, Van Gelder IC, de Kam PJ, Grandjean J, Bel KJ, Wijffels MC, Allessie MA, Crijns HJ. Verapamil reduces tachycardia- induced electrical remodeling of the atria. Circulation 1997; 95:1945–1953.
188. Azuma K, Shinmura H, Shimiza K. Significance of the sinoatrial node on mechanism of occurrence of atrial fibrillation. Br Heart J 1972; 13:84–98.
189. Sani T, Suzaki F, Sato S. Sinus node impulses and atrial fibrillation. Circ Res 1967;21:507–513.
190. Liu L, Nattel S. Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. Am J Physiol 1997; 273:H805-H816.
191. Tai CT, Chiou CW, Wen ZC, Hsieh MH, Tsai CF, Lin WS, Chen CC, Lin YK, Yu WC, Ding YA, Chang MS, Chen SA. Effect of phenylephrine on focal atrial fibrillation originating in the pulmonary veins and superior vena cava. J Am Coll Cardiol 2000; 36:788–793.
192. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999; 100(18):1879–1886.
193. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339:659–666.
194. Wit AL, Cranefield PF. Triggered and automatic activity in the canine coronary sinus. Circ Res 1977; 41:434–445.
195. Lewis T, Drury AN, Bulgar HA. Observations upon flutter and fibrillation: Part VII The effect of vagal stimulation. Heart 1921; 8:141–169.
196. Nahum LH, Hoff HE. Production of auricular fibrillation by application of acetyl-beta-methyl-choline chloride to localized region of the auricular surface. Am J Physiol 1990; 129:428–436.
197. Coumel P. Neural aspects of paroxysmal atrial fibrillation. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanism and Management. New York: Raven Press, 1992:109–125.
198. Coumel P. Neural aspects of paroxysmal atrial fibrillation in man. Br Heart J 1972; 34:520–525.
199. Coumel P, Leclercq JF. Cardiac arrhythmias and the autonomic nervous system. In: Levy S, Scheinman MM, eds. Cardiac Arrhythmias from Diagnosis to Therapy. Mt Kisco, NY: Futura, 1984:37.